Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cavalot

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|September 17, 2013
Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetesF Cavalot
Diabetes, Obesity & Metabolism|September 17, 2013
Daily glycaemic variability: benefits of optimal controlF Cavalot
Diabetes, Nutrition & Metabolism|April 8, 2003
Afternoon hypoglycaemia in Type 2 diabetes: lessons from blood glucose profilesM Trovati, M Traversa, F Cavalot
Diabetes, Obesity & Metabolism|September 17, 2013
How can we monitor glycaemic variability in the clinical setting?S Inchiostro, R Candido, F Cavalot
Human Pathology|October 1, 1988
Recent progress in renal immunopathologyG Andres, Y Yuzawa, F Cavalot
Minerva Gastroenterologica E Dietologica|January 1, 1991
[Primary sclerosing cholangitis associated with colonic Crohn disease and marked eosinophilia. Description of a case]E Gaia, F Cavalot, P De Giuli, et al.
Diabetes Research and Clinical Practice|April 8, 2018
Outcomes of integrated management versus specialized care for patients with type 2 diabetes: An observational studyI Sabione, F Cavalot, P Paccotti, et al.
General Pharmacology|October 1, 1994
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human plateletsG Anfossi, P Massucco, E Mularoni, et al.
European Journal of Clinical Investigation|May 31, 2001
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human plateletsG Anfossi, I Russo, P Massucco, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 1, 1993
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprostG Anfossi, P Massucco, E Mularoni, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|September 17, 2013
Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetesF Cavalot
Diabetes, Obesity & Metabolism|September 17, 2013
Daily glycaemic variability: benefits of optimal controlF Cavalot
Diabetes, Nutrition & Metabolism|April 8, 2003
Afternoon hypoglycaemia in Type 2 diabetes: lessons from blood glucose profilesM Trovati, M Traversa, F Cavalot
Diabetes, Obesity & Metabolism|September 17, 2013
How can we monitor glycaemic variability in the clinical setting?S Inchiostro, R Candido, F Cavalot
Human Pathology|October 1, 1988
Recent progress in renal immunopathologyG Andres, Y Yuzawa, F Cavalot
Minerva Gastroenterologica E Dietologica|January 1, 1991
[Primary sclerosing cholangitis associated with colonic Crohn disease and marked eosinophilia. Description of a case]E Gaia, F Cavalot, P De Giuli, et al.
Diabetes Research and Clinical Practice|April 8, 2018
Outcomes of integrated management versus specialized care for patients with type 2 diabetes: An observational studyI Sabione, F Cavalot, P Paccotti, et al.
General Pharmacology|October 1, 1994
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human plateletsG Anfossi, P Massucco, E Mularoni, et al.
European Journal of Clinical Investigation|May 31, 2001
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human plateletsG Anfossi, I Russo, P Massucco, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 1, 1993
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprostG Anfossi, P Massucco, E Mularoni, et al.
Pageof 7